https://vimeo.com/789780968%20
Experts shared the latest information on emerging CLL research and clinical trials, including news from the 2022 American Society of Hematology (ASH) annual conference and responded to audience questions.
Expert Panel:
![michael_keating.edit michael_keating.edit](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/michael_keating.edit_-qcwl9vzn3qcda7v1xdxarsz6buuvpopy5p4lmal780.jpg)
Dr. Michael Keating, Founder, CLL Global Research Foundation
![xwilliam_wierda.resize400 xwilliam_wierda.resize400](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/xwilliam_wierda.resize400-qcwl9v1swwb2ylwf2vio7b7pqgzihzm7tkh450mle8.jpg)
Dr. William Wierda, President & CEO, CLL Global Research Foundation
![nitin_resize400 nitin_resize400](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/nitin_resize400-qcwl9vzn3qcda7v1xdxarsz6buuvpopy5p4lmal780.jpg)
Dr. Nitin Jain, Associate Professor in the Department of Leukemia, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center
![jeff.edit jeff.edit](https://www.cllglobal.org/wp-content/uploads/elementor/thumbs/jeff.edit_-qcwl9vzn3qcda7v1xdxarsz6buuvpopy5p4lmal780.jpg)
Jeff Folloder, Moderator and CLL patient advocate